Furst, Arthur, Ph.D., Sc.D.
(Toxicologist, U of CA, San Francisco, Industry Expert)Arthur Furst was an Industry Consultant, CTR Consultant, CTR Contract and CTR Special Project recipient. (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996) He is an Expert of General Causation and Specific Causation and he gave a deposition that was 242 pgs on 12/3/86 for the Cipollone v. Liggett, et al case. (PMI's Revised Initial Disclosure, June 27, 1996). Furst was a toxicologist and Graduate of Stanford University. He is retired, but is still a consultant to the cigarette industry. He testified that smoking had not been proved to cause lung cancer. Much of Furst's research was paid for in full or in part by the tobacco industry-funded Council for Tobacco Research, before 1965. He testified for the defense in the Galbraith trial, admitting that smoking was a risk factor for cancer. (Jenkins, pp. 165/66). He testified for the defense in the Cipollone case. Furst was used as a support to the Microbiological Associates' mouse study, which found no squamous-cell carcinoma (although the lab's director of inhalation toxicology, Dr. Carol Henry, says the study built a very strong case that cigarettes can induce cancers in animals). Furst also used as support the Bio-Research Institute hamster study, which found only microinvasive tumors (although BRI's founder, Dr. Freddy Homberger, who used this milder wording under pressure from the CTR says it was cancer beyond any question. (WSJ 2/11/93).